全球支原体测试市场规模、份额、成长分析，按应用（细胞株测试、病毒测试）、最终用途（学术研究机构、细胞库）- 2024-2031 年产业预测

Global Mycoplasma Testing Market Size, Share, Growth Analysis, By Application(Cell Line Testing, Virus Testing), By End-Use(Academic Research Institutes, Cell Banks) - Industry Forecast 2024-2031

出版日期: 2024年04月12日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球支原体检测市场规模为2.9891亿美元，预计将从2023年的3.4076亿美元增长到2031年的9.7204亿美元，在预测期内（2024-2031年）复合年增长率为14%。

提供可靠、准确、有效的仪器和服务来识别和避免多种情况下的支原体污染是支原体检测市场的目标。该市场包括各种商品，例如仪器、软体、试剂、套件和测试，以及包括咨询、测试和验证在内的实验室服务。支原体检测市场服务于生物技术、製药、学术研究和临床诊断等众多行业。支原体检测市场受到多种原因的推动，例如对细胞疗法和生物製药的需求不断增长、人们对支原体污染的潜在危害和影响的认识不断增强，以及支原体检测复杂技术和平台的引入。此外，由于支原体检测监管标准和规范的收紧和标准化，对更可靠、更有效的检测解决方案的需求日益增长。支原体检测市场也受到许多变数的限制，包括检测商品和服务的高价格、检测方案缺乏统一和一致性，以及支原体检测基础设施和合格劳动力的稀缺。支原体检测市场还必须应对许多障碍，包括需要不断创新和增强检测产品和服务，以满足不断变化的消费者和监管需求。此外，市场还必须解决与其他污染物交叉反应、假阳性和假阴性结果以及支原体菌株遗传变异和适应的可能性等问题。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Merck KGaA (Germany)
Thermo Fisher Scientific Inc. (US)
Lonza Group Ltd. (Switzerland)
Sartorius AG (Germany)
PromoCell GmbH (Germany)
American Type Culture Collection (ATCC) (US)
Agilent Technologies, Inc. (US)
Bionique Testing Laboratories, Inc. (US)
Biological Industries Israel Beit Haemek Ltd. (Israel)
Charles River Laboratories International, Inc. (US)
Creative Bioarray (US)
InvivoGen (US)
Minerva Biolabs GmbH (Germany)
Biological Industries US, Inc. (US)
Norgen Biotek Corp. (Canada)
Novacyt Group (UK)
Mycoplasma Experience (France)
Genscript Biotech Corporation (China)
GeneCopoeia, Inc. (US)
Jena Bioscience GmbH (Germany)

简介目录

Product Code: SQMIG35I2219

Global Mycoplasma Testing Market size was valued at USD 298.91 million in 2022 and is poised to grow from USD 340.76 million in 2023 to USD 972.04 million by 2031, growing at a CAGR of 14% during the forecast period (2024-2031).

Providing dependable, accurate, and effective instruments and services for identifying and averting Mycoplasma contamination in many contexts is the aim of the mycoplasma testing market. The market includes a wide range of goods, such as instruments, software, reagents, kits, and testing, in addition to laboratory services including consulting, testing, and validation. Numerous industries, including biotechnology, pharmaceuticals, academic research, and clinical diagnostics, are served by the mycoplasma testing market. The market for mycoplasma testing is propelled by multiple causes, such as the escalating need for cell-based therapies and biopharmaceuticals, the expanding consciousness about the potential hazards and repercussions of mycoplasma contamination, and the introduction of sophisticated technologies and platforms for mycoplasma testing. Furthermore, there is a growing need for more reliable and effective testing solutions due to the tightening and standardization of regulatory criteria and norms around mycoplasma testing. The market for mycoplasma testing is also constrained by a number of variables, including the high price of testing goods and services, the lack of harmonization and consistency in testing protocols, and the scarcity of infrastructure and qualified labor for mycoplasma testing. The market for mycoplasma testing also has to contend with a number of obstacles, including the requirement for ongoing innovation and enhancement of testing goods and services in order to meet changing consumer and regulatory demands. Additionally, the market must deal with the problems of cross-reactivity with other pollutants, false-positive and false-negative results, and the possibility of genetic variability and adaptation of mycoplasma strains.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycoplasma Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycoplasma Testing Market Segmental Analysis

The global mycoplasma testing market is segmented on the application, end-use and region. By application, the market is segmented into cell line testing, virus testing, end of production cells testing, others. By end-use, the market is segmented into academic research institutes, cell banks, contract research organizations, pharmaceutical & biotechnology companies, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Mycoplasma Testing Market

The market for Mycoplasma testing is being driven by the increasing need for cell-based treatments and biopharmaceuticals. To guarantee the safety and effectiveness of these products and therapies, premium cells free of Mycoplasma contamination are needed.

Restraints in the Global Mycoplasma Testing Market

Many clients may find the high expense of mycoplasma testing goods and services to be a major deterrent, particularly in developing nations or environments with limited resources. The type of test utilized, the sample's complexity, and the test's sensitivity and specificity can all affect how much a mycoplasma test costs. Certain sophisticated testing techniques, such high-throughput sequencing or PCR-based assays, can be quite costly, rendering them unaffordable for certain clients.

Market Trends of the Global Mycoplasma Testing Market

Modern platforms and technologies, like PCR-based assays, flow cytometry, and nucleic acid sequencing, are emerging in the mycoplasma testing sector. These tools provide improved speed, sensitivity, and specificity over the conventional culture-based approaches.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Mycoplasma Testing Market by Application

Market Overview
Cell Line Testing
Virus Testing
End of Production Cells Testing
and Others

Global Mycoplasma Testing Market by End-Use

Market Overview
Academic Research Institutes
Cell Banks
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
and Others

Global Mycoplasma Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PromoCell GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
American Type Culture Collection (ATCC) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bionique Testing Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological Industries Israel Beit Haemek Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InvivoGen (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minerva Biolabs GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological Industries US, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norgen Biotek Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novacyt Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mycoplasma Experience (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneCopoeia, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jena Bioscience GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments